肝硬化的直接口服抗凝剂:理由和当前的证据
Cindy Pereira Portela1, Lucas A Gautier1, Maxime G Zermatten1,2
1Hemostasis and Platelet Research Laboratory, Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), CH-1010 Lausanne, Switzerland.
JHEP reports : innovation in hepatology
|August 5, 2024
概括
直接口服抗凝剂 (DOAC) 在治疗肝硬化患者的出血和凝血风险方面表现有前途. 研究表明,DOAC可能比传统的抗凝血剂在静脉血栓栓塞事件 (VTE) 中更安全和更有效.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝硬化显著影响血液静止,增加出血和静脉血栓栓塞事件 (VTE) 的风险.
- 目前的抗凝血标准,维生素K抗剂 (VKA) 和低分子量肝素 (LMWH),在肝硬化患者中存在局限性.
- 在肝硬化中改变的凝血,纤维解析和血小板功能使管理复杂化.
研究的目的:
- 审查在肝硬化患者中使用直接口服抗凝剂 (DOAC) 的理由.
- 在这个人群中分析不同DOAC的药理动力学和药理动力学影响.
- 评估DOAC在肝硬化患者中使用的临床结果.
主要方法:
- 在体外和体外的药理动力学和药理动力学研究的综述.
- 对临床试验数据和对DOAC在肝硬化中使用的观察性研究的分析.
- 关于肝脏疾病中抗凝血的当前文献的综合.
主要成果:
- 临床经验表明,DOAC可能是补偿性肝硬化中VTE传统抗凝剂的安全有效替代品.
- 新出现的数据表明,预防性抗凝剂可能会减少肝脏衰退.
- 具体的DOAC效应和最佳选择标准需要进一步澄清.
结论:
- DOAC 代表了管理与肝硬化相关的血栓和出血风险的潜在进展.
- 需要进行进一步的研究,以确定肝病患者最佳的DOAC选择和剂量策略.
- DOAC可能为VTE治疗和肝硬化潜在的初级预防提供了更好的结果.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
502
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
502
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Esophageal Varices-I: Introduction
96
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
96
Factors Influencing Drug Absorption: Disease States and Pharmacology
472
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
472


